Pular para o conteúdo
Malformação do sistema nervoso central
ORPHA:98044CID-10 · Q00-Q07DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Face / craniofacial
Também conhecida comoMás-formações cefálicas congênitas

Malformação do SNC é um grupo de distúrbios congênitos afetando o desenvolvimento cerebral e espinhal. Manifesta-se com fraqueza muscular, problemas de memória, dor nas costas e alterações faciais, frequentemente associados a cistos aracnoides e nefropatia.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

Mantido pelo Disease Twin100% com fonte · atualizado 27/09/2026Revisão médica pendente
Informacoes curadas por IA — podem conter imprecisoes

Visão geral

A malformação do sistema nervoso central (código MONDO:0020022, CID-10 Q00-Q07) engloba anomalias estruturais congênitas ou do desenvolvimento que afetam o sistema nervoso central.[1][2]

Sinais e sintomas

Os sinais e manifestações clínicas documentados incluem alterações neurológicas e estruturais, tais como lesão cística intracraniana, cisto espinharacnoide, cisto inter-hemisférico, morfologia anormal da meninge espinhal e hemorragia subaracnoidea.[1][2]

Podem ocorrer fraqueza muscular do membro inferior, dor no membro inferior, dor nas costas, ciática e dificuldade para ficar em pé. No aspecto oftalmológico, descrevem-se visão turva, midríase e paralisia do olhar para cima.[1][2]

Manifestações comportamentais, cognitivas e sistêmicas também são observadas, incluindo comprometimento da memória, desinibição, choro inapropriado, mania, insônia, autonegligência, deterioração social e ocupacional, além de face longa, apetite pobre, dor abdominal, nefropatia e fisiologia anormal do intestino grosso.[1][2]

Causas genéticas

Diversos genes estão associados a estas malformações, incluindo OPHN1, FRMD4A, DKK1, ZIC1, NID1, ZIC4, FAM149B1, OFD1, TCTN3, KIAA0753, AGTPBP1 e MINPP1.[1][3]

Diagnóstico

No contexto da investigação genética e molecular, constam 336 testes genéticos catalogados e 337 variantes descritas na base de dados ClinVar.[1][3][4]

Tratamento e manejo

Atualmente, a condição consta com nível de cobertura SUS como 'Sem cobertura SUS', não possuindo medicamentos incorporados ou dispensados pelo sistema público, nem procedimentos específicos catalogados nos dados oficiais.[1][4]

Tratamentos citados na literatura

A literatura científica apresenta associações com determinados fármacos e substâncias obtidas por mineração automatizada de dados (PubTator3). É importante ressaltar que essas menções representam apenas termos identificados em publicações científicas e NÃO constituem recomendação de uso clínico: Sirolimus (85 publicações), Enbucrilate (64 publicações), Onyx 18 (34 publicações), Indocyanine Green (32 publicações), ethylene vinyl alcohol copolymer (24 publicações), Propranolol (15 publicações), Steroids (15 publicações), Polyvinyl Alcohol (14 publicações), Titanium (11 publicações) e Alpelisib (9 publicações). Há também 1 ensaio clínico ativo registrado.[4]

Fontes numeradas em Referências.

Conteúdo informativo gerado e mantido automaticamente a partir de fontes oficiais (Orphanet, HPO, OMIM, SUS). Não substitui avaliação médica.

💬
EM LINGUAGEM SIMPLES

A **malformação do sistema nervoso central**, também chamada de **más-formações cefálicas congênitas**, é uma categoria que reúne várias alterações estruturais no cérebro e na medula espinhal que acontecem antes do nascimento. As pessoas afetadas podem manifestar dificuldades motoras como **tetraparesia** (fraqueza nos braços e pernas), problemas de coordenação, alterações na visão e disfunções no controle da bexiga e do intestino. O quadro clínico é investigado por meio de exames de imagem, como ultrassonografia, e por testes genéticos especializados. No Brasil, a condição não conta com um PCDT oficial de doença rara no SUS, de modo que o cuidado e as terapias de suporte são organizados individualmente pelas equipes de referência da rede pública.

📋
Informacoes curadas por IA — podem conter imprecisoes

Malformação do SNC é um grupo de distúrbios congênitos afetando o desenvolvimento cerebral e espinhal. Manifesta-se com fraqueza muscular, problemas de memória, dor nas costas e alterações faciais, frequentemente associados a cistos aracnoides e nefropatia.

Pesquisas ativas
1 ensaio
3 total registrados no ClinicalTrials.gov
Publicações científicas
102 artigos
Último publicado: 2025 Oct
Em pesquisa
3 moléculas
ETHINYL ESTRADIOL, NORGESTIMATE, ALPELISIB

O que está sendo pesquisado

3 moléculas em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
ETHINYL ESTRADIOLNORGESTIMATEALPELISIB
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.
🏥
SUS: Sem cobertura SUSScore: 20%
CID-10: Q00-Q07
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
158 sintomas
🦴
Ossos e articulações
122 sintomas
😀
Face
79 sintomas
👁️
Olhos
60 sintomas
🫃
Digestivo
46 sintomas
❤️
Coração
36 sintomas

+ 454 sintomas em outras categorias

Características mais comuns

—
Face longa
—
Cisto espinharacnoide
—
Fraqueza muscular do membro inferior
—
Deterioração social e ocupacional
—
Dor nas costas
—
Comprometimento da memória
1133sintomas
Sem dados (1133)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1133 características clínicas mais associadas, ordenadas por frequência.

Face longaLong face
Cisto espinharacnoideSpinalarachnoid cyst
Fraqueza muscular do membro inferiorLower limb muscle weakness
Deterioração social e ocupacionalSocial and occupational deterioration

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico102PubMed
Últimos 10 anos40publicações
Pico20217 papers
Linha do tempo
2025Hoje · 2026🧪 2003Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

72 genes identificados com associação a esta condição.

Curadoria gene-doença

fontes oficiais
NID1
OPHN1Oligophrenin-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
RAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOB GTPase cycleRAC1 GTPase cycle
MECANISMO DE DOENÇA

Intellectual developmental disorder, X-linked, syndromic, Billuart type

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSBL patients manifest intellectual disability associated with cerebellar hypoplasia and distinctive facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
17.3 TPM
Cervix Endocervix
16.2 TPM
Nervo tibial
15.6 TPM
Brain Nucleus accumbens basal ganglia
10.0 TPM
Próstata
9.6 TPM
OUTRAS DOENÇAS (1)
X-linked intellectual disability-cerebellar hypoplasia syndrome
HGNC:8148UniProt:O60890
FRMD4AFERM domain-containing protein 4ACandidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Agenesis of the corpus callosum, with facial anomalies and cerebellar ataxia

An autosomal recessive intellectual disability syndrome characterized by congenital microcephaly, low anterior hairline, bitemporal narrowing, low-set protruding ears, strabismus and tented thick eyebrows with sparse hair in their medial segment.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
19.8 TPM
Tecido adiposo
19.7 TPM
Artéria coronária
18.9 TPM
Nervo tibial
18.7 TPM
Baço
17.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome
HGNC:25491UniProt:Q9P2Q2
DKK1Dickkopf-related protein 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
852.9 TPM
Cervix Endocervix
17.5 TPM
Tecido adiposo
15.3 TPM
Bladder
15.0 TPM
Skin Sun Exposed Lower leg
11.6 TPM
OUTRAS DOENÇAS (2)
idiopathic juvenile osteoporosisChiari malformation type I
HGNC:2891UniProt:O94907
ZIC1Zinc finger protein ZIC 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Specification of the neural plate borderTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Craniosynostosis 6

A form of craniosynostosis, a primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
426.0 TPM
Cerebelo
311.1 TPM
Fibroblastos
8.3 TPM
Brain Spinal cord cervical c-1
8.1 TPM
Hipotálamo
7.3 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (5)
structural brain anomalies with impaired intellectual development and craniosynostosiscraniosynostosis 6isolated Dandy-Walker malformation without hydrocephalusisolated Dandy-Walker malformation with hydrocephalus
HGNC:12872UniProt:Q15915
NID1Nidogen-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Laminin interactionsDegradation of the extracellular matrix
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
326.2 TPM
Fallopian Tube
233.5 TPM
Tecido adiposo
202.4 TPM
Cervix Endocervix
201.4 TPM
Cólon sigmoide
172.8 TPM
OUTRAS DOENÇAS (1)
isolated Dandy-Walker malformation without hydrocephalus
HGNC:7821UniProt:P14543
ZIC4Zinc finger protein ZIC 4Candidate gene tested inTolerante
EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
164.0 TPM
Cerebelo
134.3 TPM
Fibroblastos
3.2 TPM
Brain Spinal cord cervical c-1
2.9 TPM
Hipotálamo
2.8 TPM
OUTRAS DOENÇAS (2)
isolated Dandy-Walker malformation with hydrocephalusisolated Dandy-Walker malformation without hydrocephalus
HGNC:20393UniProt:Q8N9L1
FAM149B1Primary cilium assembly protein FAM149B1Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 36

A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS36 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
18.4 TPM
Fibroblastos
17.3 TPM
Ovário
16.9 TPM
Brain Spinal cord cervical c-1
15.6 TPM
Nervo tibial
15.3 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
Joubert syndrome 36orofaciodigital syndrome type 6
HGNC:29162UniProt:Q96BN6
OFD1Centriole and centriolar satellite protein OFD1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (8)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Orofaciodigital syndrome 1

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by abnormalities in the oral cavity, face, and digits and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD1 is X-linked dominant syndrome, lethal in males. Craniofacial findings consist of facial asymmetry, hypertelorism, median cleft, or pseudocleft of the upper lip, hypoplasia of the alae nasi, oral clefts and abnormal frenulea, tongue anomalies (clefting, cysts, hamartoma), and anomalous dentition involving missing or extra teeth. Asymmetric brachydactyly and/or syndactyly of the fingers and toes occur frequently. Approximately 50% of OFD1 females have some degree of intellectual disability. Some patients have structural central nervous system anomalies such as agenesis of the corpus callosum, cerebellar agenesis, or a Dandy-Walker malformation. Patients with OFD1 can develop fibrocystic disease of the liver and pancreas, in addition to polycystic kidneys.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
47.1 TPM
Fallopian Tube
44.0 TPM
Tireoide
42.2 TPM
Cervix Endocervix
39.8 TPM
Útero
36.8 TPM
OUTRAS DOENÇAS (8)
Joubert syndrome 10orofaciodigital syndrome Iretinitis pigmentosa 23Simpson-Golabi-Behmel syndrome type 2
HGNC:2567UniProt:O75665
TCTN3Tectonic-3Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Orofaciodigital syndrome 4

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD4 patients have tongue nodules, multiple frenulae, broad flat nose, hypertelorism, and short rib polydactyly with tibial dysplasia (Majewski syndrome). The presence of severe tibial aplasia differentiates OFD4 from OFD1. Additional features of cystic dysplastic kidneys and brain malformation, including occipital encephalocele, are observed in severely affected patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
62.2 TPM
Tireoide
59.1 TPM
Ovário
54.1 TPM
Cervix Endocervix
50.4 TPM
Útero
50.0 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 18orofaciodigital syndrome IVMeckel syndromeJoubert syndrome
HGNC:24519UniProt:Q6NUS6
KIAA0753Protein moonrakerCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Orofaciodigital syndrome 15

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD15 features include facial dysmorphism, lobulated tongue, clefting of the alveolar ridges, left hand postaxial polydactyly, broad right hallux and left hallux duplication, and intermittent respiratory difficulty. Brain anomalies include vermis hypoplasia with molar tooth sign, agenesis of corpus callosum, and ventricular dilation. OFD15 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
26.9 TPM
Testículo
24.8 TPM
Fallopian Tube
23.7 TPM
Esôfago - Junção
22.6 TPM
Útero
19.7 TPM
OUTRAS DOENÇAS (6)
orofaciodigital syndrome XVJoubert syndrome 38short-rib thoracic dysplasia 21 without polydactylyJoubert syndrome
HGNC:29110UniProt:Q2KHM9
AGTPBP1Cytosolic carboxypeptidase 1Candidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
Carboxyterminal post-translational modifications of tubulin
MECANISMO DE DOENÇA

Neurodegeneration, childhood-onset, with cerebellar atrophy

An autosomal recessive disorder characterized by early onset of progressive neurodegeneration affecting the central and peripheral nervous systems. Clinical features include global developmental delay, impaired intellectual development, poor or absent speech, and motor abnormalities. Brain imaging shows cerebellar atrophy. Death in childhood may occur.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
neurodegeneration, childhood-onset, with cerebellar atrophypontocerebellar hypoplasia type 1
HGNC:17258UniProt:Q9UPW5
MINPP1Multiple inositol polyphosphate phosphatase 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of IPs in the ER lumen
MECANISMO DE DOENÇA

Thyroid cancer, non-medullary, 2

A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
34.1 TPM
Glândula adrenal
24.9 TPM
Ovário
14.8 TPM
Linfócitos
14.0 TPM
Pulmão
13.4 TPM
OUTRAS DOENÇAS (4)
pontocerebellar hypoplasia, type 16familial papillary or follicular thyroid carcinomapontocerebellar hypoplasia type 7thyroid cancer, nonmedullary, 2
HGNC:7102UniProt:Q9UNW1
SLC39A8Metal cation symporter ZIP8Candidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
Zinc influx into cells by the SLC39 gene family
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2N

A form of congenital disorder of glycosylation, a genetically heterogeneous group of autosomal recessive, multisystem disorders caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
85.8 TPM
Glândula salivar
36.1 TPM
Linfócitos
34.2 TPM
Adipose Visceral Omentum
25.0 TPM
Cervix Endocervix
19.0 TPM
OUTRAS DOENÇAS (1)
SLC39A8-CDG
HGNC:20862UniProt:Q9C0K1
TMEM216Transmembrane protein 216Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
TUBA1ATubulin alpha-1A chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Lissencephaly 3

A classic type lissencephaly associated with psychomotor retardation and seizures. Features include agyria or pachygyria or laminar heterotopia, severe intellectual disability, motor delay, variable presence of seizures, and abnormalities of corpus callosum, hippocampus, cerebellar vermis and brainstem.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
1761.9 TPM
Hipotálamo
655.7 TPM
Substância negra
642.6 TPM
Cérebro - Hemisfério cerebelar
562.6 TPM
Cerebelo
519.9 TPM
OUTRAS DOENÇAS (4)
lissencephaly due to TUBA1A mutationfetal akinesia deformation sequence 1tubulinopathy-associated dysgyriacongenital fibrosis of extraocular muscles
HGNC:20766UniProt:Q71U36
TUBB2BTubulin beta-2B chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Cortical dysplasia, complex, with other brain malformations 7

A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
377.8 TPM
Brain Nucleus accumbens basal ganglia
248.1 TPM
Substância negra
229.1 TPM
Hipotálamo
205.3 TPM
Brain Caudate basal ganglia
203.2 TPM
OUTRAS DOENÇAS (4)
complex cortical dysplasia with other brain malformations 7tubulinopathy-associated dysgyriacerebellar ataxia, intellectual disability, and dysequilibriumcongenital fibrosis of extraocular muscles
HGNC:30829UniProt:Q9BVA1
EMC1ER membrane protein complex subunit 1Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Cerebellar atrophy, visual impairment, and psychomotor retardation

An autosomal recessive, neurodegenerative disorder characterized by developmental delay, intellectual disability, hypotonia, scoliosis, cerebellar atrophy, and variable dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
41.9 TPM
Cérebro - Hemisfério cerebelar
18.2 TPM
Linfócitos
17.7 TPM
Útero
17.6 TPM
Ovário
17.4 TPM
OUTRAS DOENÇAS (2)
cerebellar atrophy, visual impairment, and psychomotor retardation;global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome
HGNC:28957UniProt:Q8N766
SLC35A2UDP-galactose translocatorCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Transport of nucleotide sugars
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2M

An X-linked dominant, severe neurologic disorder characterized by developmental delay, hypotonia, ocular anomalies, and brain malformations. Othere more variable clinical features included seizures, hypsarrhythmia, poor feeding, microcephaly, recurrent infections, dysmorphic features, shortened limbs, and coagulation defects. Congenital disorders of glycosylation are caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins and a wide variety of clinical features. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
22.3 TPM
Pituitária
20.4 TPM
Esôfago - Mucosa
16.9 TPM
Pulmão
16.7 TPM
Glândula salivar
16.6 TPM
OUTRAS DOENÇAS (2)
SLC35A2-congenital disorder of glycosylationisolated focal cortical dysplasia type Ia
HGNC:11022UniProt:P78381
CC2D2ACoiled-coil and C2 domain-containing protein 2ACandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 6

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

OUTRAS DOENÇAS (8)
retinitis pigmentosa 93COACH syndrome 2Joubert syndrome 9Meckel syndrome, type 6
HGNC:29253UniProt:Q9P2K1
AMPD2AMP deaminase 2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Purine salvage
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 9

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH9 features include severely delayed psychomotor development, progressive microcephaly, spasticity, seizures, and brain abnormalities, including brain atrophy, thin corpus callosum, and delayed myelination.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 63pontocerebellar hypoplasia type 9
HGNC:469UniProt:Q01433
RPL10Large ribosomal subunit protein uL16Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
Formation of a pool of free 40S subunitsRibosome Quality Control (RQC) complex extracts and degrades nascent peptideMajor pathway of rRNA processing in the nucleolus and cytosolGTP hydrolysis and joining of the 60S ribosomal subunitL13a-mediated translational silencing of Ceruloplasmin expression
MECANISMO DE DOENÇA

Autism, X-linked 5

A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
5894.2 TPM
Cervix Ectocervix
3955.8 TPM
Cervix Endocervix
3814.0 TPM
Útero
3327.9 TPM
Linfócitos
3289.1 TPM
OUTRAS DOENÇAS (4)
intellectual disability, X-linked, syndromic, 35X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndromeX-linked microcephaly-growth retardation-prognathism-cryptorchidism syndromeautism, susceptibility to, X-linked 5
HGNC:10298UniProt:P27635
VANGL1Vang-like protein 1Candidate gene tested inRestrito
VIAS BIOLÓGICAS (10)
RND1 GTPase cycleRHOU GTPase cycleRAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycle
MECANISMO DE DOENÇA

Neural tube defects

Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
13.3 TPM
Esôfago - Mucosa
9.5 TPM
Fallopian Tube
8.8 TPM
Vagina
8.1 TPM
Skin Not Sun Exposed Suprapubic
7.5 TPM
OUTRAS DOENÇAS (3)
familial caudal dysgenesiscaudal regression sequenceneural tube defects, susceptibility to
HGNC:15512UniProt:Q8TAA9
LAMA1Laminin subunit alpha-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (8)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactionsNon-integrin membrane-ECM interactions
MECANISMO DE DOENÇA

Poretti-Boltshauser syndrome

An autosomal recessive disorder characterized by cerebellar dysplasia, cerebellar vermis atrophy, cerebellar cysts in most patients, high myopia, variable retinal dystrophy, and eye movement abnormalities including strabismus, ocular apraxia, nystagmus. Affected individuals have ataxia, delayed motor development, language impairment, and intellectual disability with variable severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
22.3 TPM
Fibroblastos
17.2 TPM
Rim - Medula
6.8 TPM
Tireoide
6.6 TPM
Ovário
4.1 TPM
OUTRAS DOENÇAS (1)
ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
HGNC:6481UniProt:P25391
VRK1Serine/threonine-protein kinase VRK1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1A

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH1A is an autosomal recessive form characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and spinal cord anterior horn cells degeneration resembling infantile spinal muscular atrophy. Additional features include muscle hypotonia, congenital contractures and respiratory insufficiency that is evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.6 TPM
Testículo
41.3 TPM
Baço
13.9 TPM
Fibroblastos
12.9 TPM
Fallopian Tube
9.9 TPM
OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, autosomal recessive 10pontocerebellar hypoplasia type 1Apontocerebellar hypoplasia type 1microcephaly-complex motor and sensory axonal neuropathy syndrome
HGNC:12718UniProt:Q99986
B4GALT1Beta-1,4-galactosyltransferase 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (4)
Pre-NOTCH Processing in GolgiKeratan sulfate biosynthesisN-Glycan antennae elongationLactose synthesis
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2D

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (2)
combined low LDL and fibrinogenB4GALT1-congenital disorder of glycosylation
HGNC:924UniProt:P15291
AKT3RAC-gamma serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
OUTRAS DOENÇAS (4)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2obsolete cerebral malformationhemimegalencephalymegalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:393UniProt:Q9Y243
TBXTT-box transcription factor TDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
Epithelial-Mesenchymal Transition (EMT) during gastrulationGerm layer formation at gastrulationFormation of paraxial mesodermFormation of axial mesodermFormation of definitive endoderm
MECANISMO DE DOENÇA

Neural tube defects

Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components.

OUTRAS DOENÇAS (3)
sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndromechordomaneural tube defects, susceptibility to
HGNC:11515UniProt:O15178
TOE1Target of EGR1 protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 7

A form of pontocerebellar hypoplasia, a group of related disorders characterized by underdevelopment of the pons and the cerebellum. Pontocerebellar hypoplasia also causes impaired growth of other parts of the brain, leading to an unusually small head size. PCH7 patients manifest delayed psychomotor development, hypotonia, breathing abnormalities, and gonadal abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
37.5 TPM
Tireoide
23.1 TPM
Linfócitos
22.9 TPM
Cervix Endocervix
20.3 TPM
Baço
19.8 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 7
HGNC:15954UniProt:Q96GM8
PTF1APancreas transcription factor 1 subunit alphaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Regulation of gene expression in early pancreatic precursor cellsDevelopmental Lineage of Pancreatic Acinar Cells
MECANISMO DE DOENÇA

Pancreatic and cerebellar agenesis

A disease characterized by neonatal diabetes mellitus, cerebellar agenesis or hypoplasia, severe intrauterine growth retardation, the presence of very little subcutaneous fat, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pâncreas
30.3 TPM
Testículo
2.3 TPM
Estômago
0.8 TPM
Córtex cerebral
0.4 TPM
Brain Frontal Cortex BA9
0.4 TPM
OUTRAS DOENÇAS (3)
pancreatic agenesis 2permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndromepancreatic agenesis
HGNC:23734UniProt:Q7RTS3
UBTFNucleolar transcription factor 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
RNA Polymerase I Promoter EscapeNoRC negatively regulates rRNA expressionRNA Polymerase I Transcription TerminationRNA Polymerase I Promoter Opening
MECANISMO DE DOENÇA

Neurodegeneration, childhood-onset, with brain atrophy

An autosomal dominant neurodegenerative disease with onset in childhood, characterized by progressive cortical atrophy, developmental delay, developmental regression, loss of motor skills and ambulation, absence of language, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
72.9 TPM
Cérebro - Hemisfério cerebelar
71.6 TPM
Cervix Ectocervix
71.0 TPM
Tireoide
67.1 TPM
Útero
64.4 TPM
OUTRAS DOENÇAS (1)
childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder
HGNC:12511UniProt:P17480
SNX14Sorting nexin-14Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 20

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR20 is characterized by cerebellar atrophy, ataxia, coarsened facial features, severely delayed psychomotor development with poor or absent speech, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
58.2 TPM
Fibroblastos
33.8 TPM
Tireoide
33.7 TPM
Cérebro - Hemisfério cerebelar
32.0 TPM
Linfócitos
31.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 20
HGNC:14977UniProt:Q9Y5W7
SLC25A46Mitochondrial outer membrane protein SLC25A46Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Neuropathy, hereditary motor and sensory, 6B, with optic atrophy

An autosomal recessive neurologic disorder characterized by early-onset optic atrophy, progressive visual loss, and peripheral sensorimotor neuropathy manifesting as axonal Charcot-Marie-Tooth disease, with variable age at onset and severity. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. It is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies and primary peripheral axonal neuropathies. Peripheral axonal neuropathies are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, and normal or slightly reduced nerve conduction velocities.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
35.0 TPM
Cérebro - Hemisfério cerebelar
31.7 TPM
Fibroblastos
27.1 TPM
Cerebelo
25.2 TPM
Nervo tibial
21.7 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
neuropathy, hereditary motor and sensory, type 6Bpontocerebellar hypoplasia, type 1Epontocerebellar hypoplasia type 1hereditary motor and sensory neuropathy type 6
HGNC:25198UniProt:Q96AG3
TSEN15tRNA-splicing endonuclease subunit Sen15Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
tRNA processing in the nucleus
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 2F

A neurodevelopmental disorder characterized by progressive microcephaly, cognitive and motor delay, poor or absent speech, seizures, and spasticity. PCH2F inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
51.4 TPM
Brain Spinal cord cervical c-1
42.9 TPM
Linfócitos
39.4 TPM
Cólon sigmoide
33.2 TPM
Útero
32.2 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 2Fpontocerebellar hypoplasia type 2
HGNC:16791UniProt:Q8WW01
EXOSC9Exosome complex component RRP45Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1D

An autosomal recessive neurologic disorder with onset at birth or in infancy, and characterized by progressive axonal motor neuronopathy, severe generalized hypotonia, respiratory insufficiency, and cerebellar atrophy. Death in childhood may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
43.9 TPM
Testículo
34.6 TPM
Fibroblastos
34.4 TPM
Nervo tibial
24.9 TPM
Cérebro - Hemisfério cerebelar
23.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Dpontocerebellar hypoplasia type 1
HGNC:9137UniProt:Q06265
EXOSC8Exosome complex component RRP43Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1C

A severe autosomal recessive neurodegenerative disease characterized by cerebellar and corpus callosum hypoplasia, abnormal myelination of the central nervous system, and spinal motor neuron disease. Affected individuals manifest failure to thrive, severe muscle weakness, spasticity and psychomotor retardation. Vision and hearing are impaired.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.2 TPM
Testículo
43.8 TPM
Ovário
40.4 TPM
Cervix Endocervix
38.1 TPM
Fallopian Tube
37.8 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Cpontocerebellar hypoplasia type 1
HGNC:17035UniProt:Q96B26
COASYBifunctional coenzyme A synthaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Coenzyme A biosynthesis
MECANISMO DE DOENÇA

Neurodegeneration with brain iron accumulation 6

A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by progressive motor and cognitive dysfunction beginning in childhood or young adulthood. Patients show extrapyramidal motor signs, such as spasticity, dystonia, and parkinsonism.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
neurodegeneration with brain iron accumulation 6pontocerebellar hypoplasia, type 12
HGNC:29932UniProt:Q13057
ALX4Homeobox protein aristaless-like 4Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Parietal foramina 2

Autosomal dominant disease characterized by oval defects of the parietal bones caused by deficient ossification around the parietal notch, which is normally obliterated during the fifth fetal month. PFM2 is also a clinical feature of Potocki-Shaffer syndrome.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (6)
frontonasal dysplasia with alopecia and genital anomalyparietal foramina 2Potocki-Shaffer syndromeparietal foramina
HGNC:450UniProt:Q9H161
CPLANE1Ciliogenesis and planar polarity effector 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 17

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

OUTRAS DOENÇAS (4)
Joubert syndrome 17orofaciodigital syndrome type 6Joubert syndromemonomelic amyotrophy
HGNC:25801UniProt:Q9H799
AHI1JouberinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 3

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 3 shows minimal extra central nervous system involvement and appears not to be associated with renal dysfunction.

OUTRAS DOENÇAS (4)
Joubert syndrome 3Joubert syndromeretinitis pigmentosaJoubert syndrome with ocular defect
HGNC:21575UniProt:Q8N157
PIK3R2Phosphatidylinositol 3-kinase regulatory subunit betaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (10)
Signaling by LTK in cancerNephrin family interactionsIRS-mediated signallingTie2 SignalingDAP12 signaling
MECANISMO DE DOENÇA

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1

A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
58.3 TPM
Córtex cerebral
54.6 TPM
Ovário
54.1 TPM
Brain Frontal Cortex BA9
48.7 TPM
Pituitária
47.6 TPM
OUTRAS DOENÇAS (3)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1obsolete cerebral malformationmegalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:8980UniProt:O00459
TMEM138Transmembrane protein 138Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 16

An autosomal recessive disorder characterized by oculomotor apraxia, variable coloboma, and rare kidney involvement. Neuroradiologically, it is characterized by an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
46.1 TPM
Ovário
37.6 TPM
Fallopian Tube
34.8 TPM
Útero
32.5 TPM
Cervix Endocervix
31.2 TPM
OUTRAS DOENÇAS (2)
Joubert syndrome 16Joubert syndrome with oculorenal defect
HGNC:26944UniProt:Q9NPI0
PCLOProtein piccoloDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Sensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 3

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum. Brain MRI shows an abnormally small cerebellum and brainstem, decreased cerebral white matter, and a thin corpus callosum. PCH3 features include seizures, short stature, optic atrophy, progressive microcephaly, severe developmental delay.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
32.2 TPM
Cérebro - Hemisfério cerebelar
32.0 TPM
Pituitária
9.4 TPM
Brain Frontal Cortex BA9
7.9 TPM
Brain Nucleus accumbens basal ganglia
6.3 TPM
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 3
HGNC:13406UniProt:Q9Y6V0
TSEN2tRNA-splicing endonuclease subunit Sen2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
tRNA processing in the nucleus
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 2B

A disorder characterized by an abnormally small cerebellum and brainstem, and progressive microcephaly from birth combined with extrapyramidal dyskinesia. Severe chorea occurs and epilepsy is frequent. There are no signs of spinal cord anterior horn cells degeneration.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
11.4 TPM
Ovário
11.0 TPM
Cérebro - Hemisfério cerebelar
10.4 TPM
Útero
10.0 TPM
Fibroblastos
9.8 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia type 2Bpontocerebellar hypoplasia type 2
HGNC:28422UniProt:Q8NCE0
PIK3CAPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Signaling by LTK in cancerNephrin family interactionsIRS-mediated signallingTie2 SignalingDAP12 signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
23.2 TPM
Linfócitos
22.4 TPM
Nervo tibial
21.4 TPM
Tecido adiposo
20.5 TPM
Fibroblastos
20.5 TPM
OUTRAS DOENÇAS (28)
seborrheic keratosismegalodactylyovarian cancerhepatocellular carcinoma
HGNC:8975UniProt:P42336
NOTCH3Neurogenic locus notch homolog protein 3Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Pre-NOTCH Processing in Golgi
MECANISMO DE DOENÇA

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, 1

A cerebrovascular disease characterized by multiple subcortical infarcts, pseudobulbar palsy, dementia, and the presence of granular deposits in small cerebral arteries producing ischemic stroke.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
402.5 TPM
Aorta
222.4 TPM
Artéria coronária
208.2 TPM
Tecido adiposo
157.8 TPM
Skin Sun Exposed Lower leg
145.9 TPM
OUTRAS DOENÇAS (5)
lateral meningocele syndromemyofibromatosis, infantile, 2cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1familial partial lipodystrophy, Kobberling type
HGNC:7883UniProt:Q9UM47
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
MKS1Tectonic-like complex member MKS1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 1

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.3 TPM
Ovário
22.3 TPM
Útero
20.0 TPM
Cervix Endocervix
18.8 TPM
Pituitária
18.7 TPM
OUTRAS DOENÇAS (7)
Joubert syndrome 28Bardet-Biedl syndrome 13Meckel syndrome, type 1Joubert syndrome
HGNC:7121UniProt:Q9NXB0
TMEM231Transmembrane protein 231Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 20

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
14.2 TPM
Pituitária
13.8 TPM
Fallopian Tube
12.9 TPM
Cervix Endocervix
12.0 TPM
Útero
11.8 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 20Meckel syndrome, type 11Meckel syndromeJoubert syndrome with oculorenal defect
HGNC:37234UniProt:Q9H6L2
TSC1HamartinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
MacroautophagyEnergy dependent regulation of mTOR by LKB1-AMPKTP53 Regulates Metabolic GenesInhibition of TSC complex formation by PKBTBC/RABGAPs
MECANISMO DE DOENÇA

Tuberous sclerosis 1

An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
59.5 TPM
Cérebro - Hemisfério cerebelar
57.4 TPM
Nervo tibial
37.5 TPM
Ovário
36.5 TPM
Tireoide
35.7 TPM
OUTRAS DOENÇAS (7)
tuberous sclerosis 1isolated focal cortical dysplasia type IIlymphangioleiomyomatosistuberous sclerosis
HGNC:12362UniProt:Q92574
CCDC22Coiled-coil domain-containing protein 22Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Neddylation
MECANISMO DE DOENÇA

Ritscher-Schinzel syndrome 2

A form of Ritscher-Schinzel syndrome, a developmental malformation syndrome characterized by cerebellar brain malformations, congenital heart defects, and craniofacial abnormalities. RTSC2 is an X-linked recessive form characterized by intellectual disability associated with posterior fossa defects, cardiac malformations, and minor abnormalities of the face and distal extremities.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
Ritscher-Schinzel syndrome 2Ritscher-Schinzel syndrome
HGNC:28909UniProt:O60826
VPS51Vacuolar protein sorting-associated protein 51 homologDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Retrograde transport at the Trans-Golgi-Network
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 13

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH13 is an autosomal recessive form characterized by delayed psychomotor development, absent speech, severe intellectual disability and postnatal microcephaly, with brain malformations consisting of cerebellar atrophy and hypoplastic corpus callosum. Additional features, including seizures and visual impairment, are variable.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
152.6 TPM
Útero
102.4 TPM
Skin Sun Exposed Lower leg
100.0 TPM
Cervix Endocervix
99.7 TPM
Cérebro - Hemisfério cerebelar
99.4 TPM
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia, type 13
HGNC:HGNC:1172UniProt:Q9UID3
SEPSECSO-phosphoseryl-tRNA(Sec) selenium transferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Selenocysteine synthesis
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 2D

A disorder characterized by postnatal onset of progressive atrophy of the cerebrum and cerebellum, microcephaly, profound intellectual disability, spasticity, and variable seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
12.7 TPM
Intestino delgado
12.4 TPM
Nervo tibial
11.5 TPM
Ovário
10.7 TPM
Tireoide
10.6 TPM
OUTRAS DOENÇAS (3)
pontocerebellar hypoplasia type 2Dpontocerebellar hypoplasia type 2obsolete progressive cerebello-cerebral atrophy
HGNC:30605UniProt:Q9HD40
MSX2Homeobox protein MSX-2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Regulation of RUNX2 expression and activity
MECANISMO DE DOENÇA

Parietal foramina 1

Autosomal dominant disease characterized by oval defects of the parietal bones caused by deficient ossification around the parietal notch, which is normally obliterated during the fifth fetal month.

EXPRESSÃO TECIDUAL(Tecido-específico)
Bladder
17.6 TPM
Artéria tibial
11.3 TPM
Testículo
11.2 TPM
Cerebelo
7.3 TPM
Skin Sun Exposed Lower leg
6.0 TPM
OUTRAS DOENÇAS (4)
parietal foramina 1parietal foramina with cleidocranial dysplasiacraniosynostosis 2parietal foramina
HGNC:7392UniProt:P35548
NPHP3Nephrocystin-3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Trafficking of myristoylated proteins to the cilium
MECANISMO DE DOENÇA

Nephronophthisis 3

An autosomal recessive disorder resulting in end-stage renal disease. It is characterized by polyuria, polydipsia, anemia. Onset of terminal renal failure occurr significantly later (median age, 19 years) than in juvenile nephronophthisis. Renal pathology is characterized by alterations of tubular basement membranes, tubular atrophy and dilation, sclerosing tubulointerstitial nephropathy, and renal cyst development predominantly at the corticomedullary junction.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
63.6 TPM
Fallopian Tube
51.7 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
48.3 TPM
Nervo tibial
45.7 TPM
OUTRAS DOENÇAS (7)
NPHP3-related Meckel-like syndromenephronophthisis 3renal-hepatic-pancreatic dysplasia 1nephronophthisis 2
HGNC:7907UniProt:Q7Z494
CASKPeripheral plasma membrane protein CASKDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
Assembly and cell surface presentation of NMDA receptorsDopamine Neurotransmitter Release CycleNeurexins and neuroliginsNephrin family interactionsSyndecan interactions
OUTRAS DOENÇAS (4)
FG syndrome 4syndromic X-linked intellectual disability Najm typeearly-infantile DEEnon-syndromic X-linked intellectual disability
HGNC:1497UniProt:O14936
DPYSL5Dihydropyrimidinase-related protein 5Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
CRMPs in Sema3A signaling
MECANISMO DE DOENÇA

Ritscher-Schinzel syndrome 4

An autosomal dominant form of Ritscher-Schinzel syndrome, a developmental malformation syndrome characterized by cerebellar brain anomalies associated with global developmental delay and impaired intellectual development, congenital heart defects, and craniofacial abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
157.7 TPM
Brain Nucleus accumbens basal ganglia
54.8 TPM
Substância negra
43.0 TPM
Cerebelo
42.0 TPM
Cérebro - Hemisfério cerebelar
41.8 TPM
OUTRAS DOENÇAS (3)
Ritscher-Schinzel syndrome 4complex neurodevelopmental disorderRitscher-Schinzel syndrome
HGNC:20637UniProt:Q9BPU6
EXOSC3Exosome complex component RRP40Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1B

A severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. There is diffuse muscle weakness, progressive microcephaly, global developmental delay, and brainstem involvement.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
30.1 TPM
Testículo
28.1 TPM
Fibroblastos
21.2 TPM
Cervix Endocervix
16.4 TPM
Ovário
15.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia type 1Bpontocerebellar hypoplasia type 1
HGNC:17944UniProt:Q9NQT5
PRDM13PR domain zinc finger protein 13Disease-causing germline mutation(s) inModerado
MECANISMO DE DOENÇA

Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism

An autosomal recessive disorder characterized by delayed motor development, ataxia with cerebellar hypoplasia, severe progressive scoliosis, moderate to severe intellectual disability, and delayed puberty with congenital hypogonadotropic hypogonadism.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.4 TPM
Linfócitos
0.3 TPM
Hipotálamo
0.2 TPM
Brain Spinal cord cervical c-1
0.1 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, IIA 17cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism
HGNC:HGNC:13998UniProt:Q9H4Q3
AP1S2AP-1 complex subunit sigma-2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

Pettigrew syndrome

An X-linked syndrome characterized by intellectual disability and additional highly variable features, including choreoathetosis, hydrocephalus, Dandy-Walker malformation, seizures, and iron or calcium deposition in the brain. Intellectual disability is characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

OUTRAS DOENÇAS (2)
syndromic X-linked intellectual disability 5fried syndrome
HGNC:560UniProt:P56377
MTORSerine/threonine-protein kinase mTORDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
MacroautophagyEnergy dependent regulation of mTOR by LKB1-AMPKmTORC1-mediated signallingRegulation of PTEN gene transcriptionMTOR signalling
MECANISMO DE DOENÇA

Smith-Kingsmore syndrome

An autosomal dominant syndrome characterized by intellectual disability, macrocephaly, seizures, umbilical hernia, and facial dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
35.5 TPM
Cerebelo
27.1 TPM
Cérebro - Hemisfério cerebelar
26.0 TPM
Útero
20.1 TPM
Nervo tibial
19.8 TPM
OUTRAS DOENÇAS (7)
isolated focal cortical dysplasia type IImacrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndromeobsolete cerebral malformationovergrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
HGNC:3942UniProt:P42345
TELO2Telomere length regulation protein TEL2 homologDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

You-Hoover-Fong syndrome

A syndrome characterized by severe global developmental delay, intellectual disability, dysmorphic facial features, microcephaly, abnormal movements, congenital heart disease comprising developmental abnormalities of the great vessels, and abnormal auditory and visual function. The transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
65.6 TPM
Cérebro - Hemisfério cerebelar
62.6 TPM
Baço
51.0 TPM
Cervix Endocervix
49.7 TPM
Fallopian Tube
46.9 TPM
OUTRAS DOENÇAS (1)
TELO2-related intellectual disability-neurodevelopmental disorder
HGNC:29099UniProt:Q9Y4R8
VPS53Vacuolar protein sorting-associated protein 53 homologDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Retrograde transport at the Trans-Golgi-Network
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 2E

An autosomal recessive neurodegenerative disorder characterized by progressive cerebello-cerebral atrophy, profound intellectual disability, progressive microcephaly, spasticity, and early-onset epilepsy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
31.8 TPM
Cerebelo
31.1 TPM
Testículo
13.2 TPM
Córtex cerebral
11.1 TPM
Tireoide
11.0 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia type 2Eobsolete progressive cerebello-cerebral atrophy
HGNC:25608UniProt:Q5VIR6
CCND2G1/S-specific cyclin-D2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Cyclin D associated events in G1
MECANISMO DE DOENÇA

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3

A syndrome characterized by megalencephaly, ventriculomegaly that may lead to hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.

OUTRAS DOENÇAS (2)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:1583UniProt:P30279
POLR3BDNA-directed RNA polymerase III subunit RPC2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cytosolic sensors of pathogen-associated DNA
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism

An autosomal recessive neurodegenerative disorder characterized by early childhood onset of cerebellar ataxia and mild intellectual disabilities associated with diffuse hypomyelination apparent on brain MRI. Variable features include oligodontia and/or hypogonadotropic hypogonadism.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.8 TPM
Skin Sun Exposed Lower leg
9.5 TPM
Esôfago - Mucosa
8.9 TPM
Skin Not Sun Exposed Suprapubic
8.5 TPM
Vagina
8.0 TPM
OUTRAS DOENÇAS (3)
hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadismCharcot-Marie-Tooth disease, demyelinating, IIA 1Iobsolete hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome
HGNC:30348UniProt:Q9NW08
TMEM237Transmembrane protein 237Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Joubert syndrome 14

An autosomal recessive disorder characterized by severe intellectual disability, hypotonia, breathing abnormalities in infancy, and dysmorphic facial features. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include renal disease, abnormal eye movements, and postaxial polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
30.8 TPM
Skin Not Sun Exposed Suprapubic
24.6 TPM
Skin Sun Exposed Lower leg
22.7 TPM
Artéria tibial
20.4 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 14Meckel syndromeJoubert syndrome with oculorenal defectJoubert syndrome
HGNC:14432UniProt:Q96Q45
VPS35LVPS35 endosomal protein-sorting factor-likeDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Ritscher-Schinzel syndrome 3

A form of Ritscher-Schinzel syndrome, a developmental malformation syndrome characterized by cerebellar brain malformations, congenital heart defects, and craniofacial abnormalities. RTSC3 is an autosomal recessive form. Affected individuals show cranio-cerebello-cardiac anomalies, coloboma, microphthalmia, chondrodysplasia punctata, complicated skeletal malformations, periventricular nodular heterotopia and proteinuria.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
Ritscher-Schinzel syndrome 3Ritscher-Schinzel syndrome
HGNC:24641UniProt:Q7Z3J2
WASHC5WASH complex subunit 5Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 8, autosomal dominant

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
59.7 TPM
Artéria tibial
29.9 TPM
Útero
29.4 TPM
Tecido adiposo
28.6 TPM
Linfócitos
28.2 TPM
OUTRAS DOENÇAS (3)
Ritscher-Schinzel syndrome 1hereditary spastic paraplegia 8Ritscher-Schinzel syndrome
HGNC:28984UniProt:Q12768
CHMP1ACharged multivesicular body protein 1aDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
HCMV Late Events
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 8

An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 8
HGNC:8740UniProt:Q9HD42
RARS2Probable arginine--tRNA ligase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 6

A disorder characterized by an abnormally small cerebellum and brainstem, infantile encephalopathy, generalized hypotonia, lethargy and poor feeding. Recurrent apnea, intractable seizures occur early in the course of this condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
47.3 TPM
Glândula adrenal
46.1 TPM
Útero
43.0 TPM
Cervix Ectocervix
42.3 TPM
Cervix Endocervix
42.1 TPM
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 6
HGNC:21406UniProt:Q5T160
CLP1Polyribonucleotide 5'-hydroxyl-kinase Clp1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
mRNA 3'-end processingDengue Virus-Host InteractionsProcessing of Intronless Pre-mRNAsRNA Polymerase II Transcription TerminationmRNA Polyadenylation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 10

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH10 features include cortical dysgenesis marked by a simplified gyral pattern, cortical atrophy, mild or focal cerebellar vermian volume loss, delayed myelination, progressive microcephaly, global growth and developmental delays, severe intellectual disabilities, and seizures refractory to treatment.

OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 10
HGNC:16999UniProt:Q92989
TSEN54tRNA-splicing endonuclease subunit Sen54Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
tRNA processing in the nucleus
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 4

A disorder characterized by an abnormally small cerebellum and brainstem, severe neonatal encephalopathy, microcephaly, myoclonus and muscular hypertonia. There is a severe inferior olivary and pontine neuronal loss and a diffuse white matter gliosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
61.6 TPM
Cérebro - Hemisfério cerebelar
59.4 TPM
Baço
34.8 TPM
Tireoide
34.5 TPM
Próstata
33.2 TPM
OUTRAS DOENÇAS (4)
pontocerebellar hypoplasia type 4pontocerebellar hypoplasia type 2Apontocerebellar hypoplasia type 5pontocerebellar hypoplasia type 2
HGNC:27561UniProt:Q7Z6J9
CEP41Centrosomal protein of 41 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 15

An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly.

OUTRAS DOENÇAS (3)
Joubert syndrome 15Joubert syndromeJoubert syndrome with ocular defect
HGNC:12370UniProt:Q9BYV8

Medicamentos e terapias

ETHINYL ESTRADIOLPhase 3

Mecanismo: Estrogen receptor alpha agonist

NORGESTIMATEPhase 3

Mecanismo: Progesterone receptor agonist

ALPELISIBPhase 2

Mecanismo: PI3-kinase p110-alpha subunit inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

337 variantes patogênicas registradas no ClinVar.

🧬 OPHN1: NM_002547.3(OPHN1):c.826G>T (p.Glu276Ter) ()
🧬 OPHN1: NM_002547.3(OPHN1):c.939del (p.Leu314fs) ()
🧬 OPHN1: NM_002547.3(OPHN1):c.2311del (p.Ile771fs) ()
🧬 OPHN1: NM_002547.3(OPHN1):c.568G>T (p.Glu190Ter) ()
🧬 OPHN1: NM_002547.3(OPHN1):c.2048del (p.Lys683fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

226 vias biológicas associadas aos genes desta condição.

RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOQ GTPase cycle RHOG GTPase cycle RHOJ GTPase cycle RAC3 GTPase cycle Keratinocyte stem cell differentiates into transit amplifying cell in the basal layer of interfollicular epidermis TCF dependent signaling in response to WNT Negative regulation of TCF-dependent signaling by WNT ligand antagonists Signaling by LRP5 mutants Specification of the neural plate border Transcriptional and post-translational regulation of MITF-M expression and activity Degradation of the extracellular matrix Laminin interactions Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Hedgehog 'off' state Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2 Carboxyterminal post-translational modifications of tubulin Synthesis of IPs in the ER lumen Zinc influx into cells by the SLC39 gene family Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly MHC class II antigen presentation Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Cargo trafficking to the periciliary membrane Intraflagellar transport RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-dependent Golgi-to-ER retrograde traffic COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint HCMV Early Events Assembly and cell surface presentation of NMDA receptors Activation of AMPK downstream of NMDARs Aggrephagy EML4 and NUDC in mitotic spindle formation Sealing of the nuclear envelope (NE) by ESCRT-III Kinesins Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) Transport of nucleotide sugars Purine salvage L13a-mediated translational silencing of Ceruloplasmin expression Peptide chain elongation SRP-dependent cotranslational protein targeting to membrane Viral mRNA Translation Selenocysteine synthesis Major pathway of rRNA processing in the nucleolus and cytosol Formation of a pool of free 40S subunits GTP hydrolysis and joining of the 60S ribosomal subunit Eukaryotic Translation Termination Regulation of expression of SLITs and ROBOs Response of EIF2AK4 (GCN2) to amino acid deficiency Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA RHOD GTPase cycle RHOH GTPase cycle RHOU GTPase cycle RHOV GTPase cycle RHOF GTPase cycle RND3 GTPase cycle RND2 GTPase cycle RND1 GTPase cycle Non-integrin membrane-ECM interactions ECM proteoglycans L1CAM interactions MET activates PTK2 signaling Attachment of bacteria to epithelial cells Formation of the dystrophin-glycoprotein complex (DGC) Developmental Lineage of Pancreatic Ductal Cells Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Pre-NOTCH Processing in Golgi Keratan sulfate biosynthesis Interaction With Cumulus Cells And The Zona Pellucida Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) Defective B4GALT1 causes CDG-2d Lactose synthesis Neutrophil degranulation N-Glycan antennae elongation Activation of BAD and translocation to mitochondria PIP3 activates AKT signaling Downregulation of ERBB2:ERBB3 signaling AKT phosphorylates targets in the cytosol AKT phosphorylates targets in the nucleus Negative regulation of the PI3K/AKT network AKT-mediated inactivation of FOXO1A CD28 dependent PI3K/Akt signaling Co-inhibition by CTLA4 G beta:gamma signalling through PI3Kgamma VEGFR2 mediated vascular permeability TP53 Regulates Metabolic Genes Constitutive Signaling by AKT1 E17K in Cancer Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors Cyclin E associated events during G1/S transition Cyclin A:Cdk2-associated events at S phase entry RAB GEFs exchange GTP for GDP on RABs RUNX2 regulates genes involved in cell migration Regulation of PTEN stability and activity FLT3 Signaling Regulation of localization of FOXO transcription factors Estrogen-dependent nuclear events downstream of ESR-membrane signaling KEAP1-NFE2L2 pathway SARS-CoV-2 targets host intracellular signalling and regulatory pathways Cardiogenesis Germ layer formation at gastrulation Epithelial-Mesenchymal Transition (EMT) during gastrulation Formation of paraxial mesoderm Formation of axial mesoderm Formation of definitive endoderm Regulation of gene expression in early pancreatic precursor cells Developmental Lineage of Pancreatic Acinar Cells NoRC negatively regulates rRNA expression RNA Polymerase I Promoter Opening RNA Polymerase I Transcription Initiation RNA Polymerase I Promoter Escape RNA Polymerase I Transcription Termination tRNA processing in the nucleus ATF4 activates genes in response to endoplasmic reticulum stress mRNA decay by 3' to 5' exoribonuclease Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA Nuclear RNA decay Coenzyme A biosynthesis PI3K Cascade IRS-mediated signalling GPVI-mediated activation cascade Interleukin-7 signaling Signaling by SCF-KIT Synthesis of PIPs at the plasma membrane Downstream signal transduction PI3K/AKT activation Signaling by ALK Downstream TCR signaling Role of phospholipids in phagocytosis Tie2 Signaling Constitutive Signaling by Aberrant PI3K in Cancer DAP12 signaling Role of LAT2/NTAL/LAB on calcium mobilization Nephrin family interactions G alpha (q) signalling events VEGFA-VEGFR2 Pathway Interleukin-3, Interleukin-5 and GM-CSF signaling RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling RET signaling Extra-nuclear estrogen signaling Sensory processing of sound by inner hair cells of the cochlea Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants PI3K events in ERBB4 signaling GAB1 signalosome Signaling by cytosolic FGFR1 fusion mutants PI3K events in ERBB2 signaling Constitutive Signaling by EGFRvIII PI-3K cascade:FGFR1 PI-3K cascade:FGFR2 PI-3K cascade:FGFR3 PI-3K cascade:FGFR4 Pre-NOTCH Processing in the Endoplasmic Reticulum Pre-NOTCH Transcription and Translation Notch-HLH transcription pathway Defective LFNG causes SCDO3 NOTCH3 Activation and Transmission of Signal to the Nucleus NOTCH3 Intracellular Domain Regulates Transcription Noncanonical activation of NOTCH3 Macroautophagy Inhibition of TSC complex formation by PKB Energy dependent regulation of mTOR by LKB1-AMPK TBC/RABGAPs Neddylation Retrograde transport at the Trans-Golgi-Network Regulation of RUNX2 expression and activity Trafficking of myristoylated proteins to the cilium Miscellaneous transport and binding events CRMPs in Sema3A signaling Nef mediated downregulation of MHC class I complex cell surface expression Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis MTOR signalling mTORC1-mediated signalling HSF1-dependent transactivation Regulation of PTEN gene transcription Amino acids regulate mTORC1 High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Dengue virus modulates apoptosis Cyclin D associated events in G1 Regulation of RUNX1 Expression and Activity Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) Drug-mediated inhibition of CDK4/CDK6 activity Cytosolic sensors of pathogen-associated DNA RNA Polymerase III Chain Elongation RNA Polymerase III Transcription Termination RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter HCMV Late Events Mitochondrial tRNA aminoacylation mRNA 3'-end processing RNA Polymerase II Transcription Termination Processing of Intronless Pre-mRNAs mRNA Polyadenylation Dengue Virus-Host Interactions

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 22
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Malformação do sistema nervoso central

Centros de Referência SUS

24 centros habilitados pelo SUS para Malformação do sistema nervoso central

Centros para Malformação do sistema nervoso central

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 2 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

3 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
40 papers (10 anos)
#1

13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies.

International journal of molecular sciences2025 Sep 23

The expanded newborn screening (NBS) program in the Russian Federation, launched in 2023, includes the detection of severe forms of T- and B-cell immunodeficiencies via TREC/KREC quantification. We report a rare case of a male infant having multiple congenital anomalies and lymphopenia identified through this program. Genetic testing revealed a 25.8 Mb terminal deletion spanning 13q31.2-qter, consistent with 13q deletion syndrome. Initial NBS revealed reduced TREC levels, prompting further evaluation. The patient exhibited a complex phenotype, including central nervous system malformation (alobar holoprosencephaly), severe congenital heart disease, renal hypoplasia, limb and genitourinary anomalies, and facial dysmorphism. Postnatal complications included pneumonia, pleuritis, and chylothorax. Flow cytometry demonstrated mild T- and B-cell lymphopenia. The genomic defect was characterized using long-read third-generation sequencing, enabling precise breakpoint identification and accurate mapping of deleted genes. The deletion was confirmed via subtelomeric FISH analysis. The patient died at 7 months of age due to the progression of underlying congenital anomalies and associated complications. Our findings broaden the clinical characterization of distal 13q deletion syndrome and demonstrate the value of long-read sequencing in structural chromosomal analysis. They further highlight the difficulties of caring for neonates having complex malformations and immune dysfunction. Given the potential for both primary and secondary immune disturbances, comprehensive immunological evaluation should be considered in patients having 13q deletion syndrome to improve diagnostic accuracy and inform appropriate clinical management.

#2

Dandy-Walker Malformation and Optic Nerve Hypoplasia: A Developmental Case Highlighting the Psychiatric Impact of Central Nervous System Malformation.

Cureus2025 Oct

Dandy-Walker malformation (DWM) and optic nerve hypoplasia (ONH) are rare congenital anomalies associated with neuropsychiatric morbidity, but their co-occurrence in adults has not been described. We present an adult patient with both DWM and unilateral ONH who developed auditory hypersensitivity, visual agnosia, phonological dyslexia, dysgraphia, and longstanding academic challenges, later evolving into recurrent depression, anxiety, and insomnia. Neuroimaging revealed a Dandy-Walker variant with cerebellar atrophy and ONH, and her presentation was consistent with cerebellar cognitive affective syndrome. Notably, despite the established risk of autism spectrum-like traits in both DWM and ONH, she did not demonstrate autistic features. This case highlights how overlapping congenital anomalies may synergistically increase vulnerability to psychiatric illness and underscores the importance of early recognition and tailored interventions. To our knowledge, this is among the first adult cases describing co-occurring DWM and ONH with a longitudinal psychiatric course.

#3

Poland Anomaly and Atretic Cephalocele in the Same Child: Coincidence or Association?

American journal of medical genetics. Part A2025 Dec

Poland Anomaly is a rare congenital disorder typically characterized by hypoplasia or agenesis of pectoral muscle with or without ipsilateral limb hypoplasia. The association of central nervous system malformation with Poland Anomaly has been rarely reported and includes craniofacial dysplasia, microcephaly, and Dandy-Walker malformation. However, no anomalies in neural tube closure have been described in association with Poland Anomaly. Atretic cephalocele is another rare diagnosis, which is an involuted congenital herniation of intracranial contents through defects in the skull. Herein, we present the case of a child affected with Poland Anomaly in whom an atretic cephalocele has been diagnosed at the age of 2 months.

#4

Risk factors associated with congenital central nervous system abnormalities in the National Hospital of Zinder, Niger.

Neuro-Chirurgie2024 Mar

Congenital malformations of the central nervous system (CNS) are morphological abnormalities of the brain and spinal cord that occur during fetal development. They constitute the second most common congenital disability, after congenital cardiac defects. Many risk factors have been identified; however, these studies included various types of congenital abnormality. Furthermore, there is a lack of information on risk factors for congenital CNS malformation, and notably in the Zinder region of Niger. This study aimed to identify the risk factors associated with congenital CNS malformations in the Zinder region. In a case-control design, patients with congenital CNS malformation were enrolled between June 2022 and April 2023 in the Department of Neurosurgery of the National Hospital of Zinder. Family history of malformation (aOR:3.31, 95% CI:1.25-8.78) and consanguine marriage (aOR:2.28, 95% CI:1.23-4.20) were significantly associated with congenital CNS malformation. In contrast, folic acid supplementation (aOR:0.34, 95% CI:0.13, 0.89), multiparity (aOR:0.34, 95% CI:0.13, 0.89), and grand multiparity (aOR, 0.47; 95% CI:0.23, 0.97) had a protective effect. Risk factors such as family malformation history and consanguine marriage increased the risk of developing congenital malformations of the central nervous system. In contrast, folic acid supplementation in the index period and multiparity had a significant protective effect.

#5

Levetiracetam prescription profile in children younger than 4 years treated at a tertiary care hospital in Chile.

Archivos argentinos de pediatria2024 Aug 01

Introduction. Levetiracetam (LEV) is an antiepileptic drug approved by the Chilean Institute of Public Health as concomitant therapy for epileptic seizures in children older than 4 years of age. However, it is widely prescribed from the neonatal period, which makes it necessary to evaluate its off-label use. Objective. To determine the prescription-indication profile of LEV in the treatment of epileptic seizures in children younger than 4 years in a tertiary care hospital in southern Chile. Population and method. Observational, descriptive, and retrospective study. The medical records of patients who started treatment with LEV between 2014 and 2019 were reviewed, and data on sociodemographic, pharmacological, and clinical variables were collected. The analysis was based on the description of the profile of patients, prescriptions, follow-up, and safety. Results. A total of 68 patients were included: 40 (58.8%) were males, 49 (72.1%) were born at a gestational age ≥ 37 weeks. The main etiology of epilepsy was structural (35.3%); LEV was mostly used in children diagnosed with central nervous system malformation (17.6%), and monotherapy was the prevailing dosage (55.9%). LEV was used for focal seizures in 50% of cases. Five children (7.3%) had psychiatric disorders, classified as probable adverse drug reactions. Conclusion. LEV was used in children with various diagnoses, with a low rate of adverse events. The profile of drug use varied in the different age groups. Future studies are needed to identify effectiveness, especially in newborn infants and patients with refractory epilepsy. Introducción. El levetiracetam (LEV) es un antiepiléptico aprobado por el Instituto de Salud Pública de Chile como terapia concomitante en crisis epilépticas en niños mayores de cuatro años. Sin embargo, es ampliamente indicado desde el periodo neonatal, lo que hace necesario evaluar su utilización fuera de ficha técnica. Objetivo. Determinar el perfil de prescripción-indicación de LEV en el tratamiento de las crisis epilépticas en menores de cuatro años en un hospital de alta complejidad del sur de Chile. Población y método. Estudio observacional, descriptivo y retrospectivo. Se revisaron las historias clínicas de quienes iniciaron tratamiento con LEV entre 2014 y 2019, y se recopilaron datos sobre variables sociodemográficas, farmacológicas y clínicas. El análisis se basó en la descripción del perfil de los pacientes, prescripción, seguimiento y seguridad. Resultados. Se incluyeron 68 pacientes: 40 (58,8 %) de sexo masculino, 49 (72,1 %) con edad gestacional ≥ 37 semanas. La etiología principal de la epilepsia fue de tipo estructural (35,3 %); el LEV se utilizó principalmente en niños diagnosticados con malformación del sistema nervioso central (17,6 %) y predominó la monoterapia (55,9 %). En el 50 % se usó LEV para crisis focales. Cinco niños (7,3 %) presentaron trastornos de tipo psiquiátrico clasificados como probables reacciones adversas al medicamento. Conclusión. El LEV se utilizó en niños con diferentes diagnósticos con baja frecuencia de eventos adversos. El perfil de utilización varió en los diferentes grupos etarios. Es necesario identificar en futuros estudios la efectividad especialmente en el recién nacido y en epilepsias refractarias.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC15 artigos no totalmostrando 40

2025

Dandy-Walker Malformation and Optic Nerve Hypoplasia: A Developmental Case Highlighting the Psychiatric Impact of Central Nervous System Malformation.

Cureus
2025

13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies.

International journal of molecular sciences
2025

Poland Anomaly and Atretic Cephalocele in the Same Child: Coincidence or Association?

American journal of medical genetics. Part A
2024

Risk factors associated with congenital central nervous system abnormalities in the National Hospital of Zinder, Niger.

Neuro-Chirurgie
2024

Levetiracetam prescription profile in children younger than 4 years treated at a tertiary care hospital in Chile.

Archivos argentinos de pediatria
2024

Dandy-Walker Malformation with Neonatal Meningitis: A Case Report.

JNMA; journal of the Nepal Medical Association
2024

Whole-genome sequencing in prenatally detected congenital malformations: prospective cohort study in clinical setting.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2023

Epilepsy Frequency and Risk Factors Three Years After Neonatal Seizures.

Pediatric neurology
2023

The Relationship Between Fetal Central Nervous System Malformations and Modified Myocardial Performance Index.

Cureus
2023

The impact of epilepsy and antiseizure medications on pregnancy and neonatal outcomes: A nationwide cohort study.

Brain and behavior
2023

Vascular anomaly, lipoma, and polymicrogyria associated with schizencephaly: developmental and diagnostic insights. Illustrative case.

Journal of neurosurgery. Case lessons
2022

Autosomal Recessive Primary Microcephaly (MCPH) and Novel Pathogenic Variants in ASPM and WDR62 Genes.

Molecular syndromology
2022

Ultrasound Appearance of Fetal Posterior Fossa and a Case Report of Prenatal Diagnosis of Dandy-Walker Malformation.

Maedica
2022

Opioid exposure during pregnancy and the risk of congenital malformation: a meta-analysis of cohort studies.

BMC pregnancy and childbirth
2022

Case Report: Preimplantation Genetic Testing for Meckel Syndrome Induced by Novel Compound Heterozygous Mutations of MKS1.

Frontiers in genetics
2022

Alobar Holoprosencephaly in an Aborted American Quarter Horse Fetus.

Journal of equine veterinary science
2022

Use of real-time artificial intelligence in detection of abnormal image patterns in standard sonographic reference planes in screening for fetal intracranial malformations.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2021

Traumatic epidural hematoma in a patient with severe schizencephaly.

Clinical case reports
2021

Accuracy of ultrasonography in diagnosis of fetal central nervous system malformation.

World journal of clinical cases
2021

Carbamazepine-Responsive Chorea in a Toddler with Semilobar Holoprosencephaly: Case Report.

Journal of pediatric neurosciences
2021

Prenatal diagnosis of the Dandy-Walker malformation associated with partial trisomy 12p and distal 15q deletion.

Journal of genetics
2021

Prenatal Diagnosis of Acromelic Frontonasal Dysostosis.

Molecular syndromology
2021

Massive posterior cranial vault erosion and its reconstruction: A peculiar presentation of "mega cisterna magna".

Journal of oral biology and craniofacial research
2021

Application of Ultrasonic Doppler Technology Based on Wavelet Threshold Denoising Algorithm in Fetal Heart Rate and Central Nervous System Malformation Detection.

World neurosurgery
2020

Epilepsy in paediatric patients with schizencephaly.

Annals of agricultural and environmental medicine : AAEM
2020

Poland Syndrome with Atypical Malformations Associated to a de novo 1.5 Mb Xp22.31 Duplication.

Neuropediatrics
2019

Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation.

World neurosurgery
2018

Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.

Vaccine
2020

Two-year postnatal outcome of 263 cases of fetal ventriculomegaly.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2018

Cranial neural tube defect after trimethoprim exposure.

BMC research notes
2018

Neurologic Involvement in Primary Immunodeficiency Disorders.

Journal of child neurology
2018

Central nervous system malformation associated with methamphetamine abuse during pregnancy.

Clinical toxicology (Philadelphia, Pa.)
2017

Retinoic Acid Embryopathy.

International journal of applied & basic medical research
2017

Perinatal and follow-up outcome study of fetal anomalies with multidisciplinary consultation.

Therapeutics and clinical risk management
2017

Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans.

Scientifica
2016

Arthrogryposis-renal tubular dysfunction-cholestasis syndrome: a cause of neonatal cholestasis. Case report.

Archivos argentinos de pediatria
2016

Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2015

Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele.

Urologia internationalis
2015

Meckel-Gruber Syndrome with unilateral renal agenesis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2015

Evaluation of the association of zoonotic Ljungan virus with perinatal deaths and fetal malformation.

Birth defects research. Part C, Embryo today : reviews

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Malformação do sistema nervoso central.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Malformação do sistema nervoso central e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

Trata-se de um grupo amplo de anomalias congênitas estruturais que atingem o encéfalo e a medula espinhal. Na classificação internacional de doenças, o conjunto é catalogado sob o código CID-10 Q00-Q07 e ORPHA:98044.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 fontes citadas no texto · 5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. MONDO
    purl.obolibrary.org
  2. GARD:19394
    GARD (NIH)
  3. Q584265
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (2026). Malformação do sistema nervoso central. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/malformacao-do-sistema-nervoso-central

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Malformação do sistema nervoso central
Compêndio · Raras BR

Malformação do sistema nervoso central

ORPHA:98044 · MONDO:0020022
CID-10
Q00-Q07 · Anencefalia e malformações similares
Ensaios
1 ativos
Medicamentos
3 registrados
MedGen
UMLS
C0158538
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara